Skip to search formSkip to main contentSkip to account menu

HS 1030

Known as: HS-1030 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Ursodiol
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Synthetic bile acid derivatives inhibit cell proliferation and induce apoptosis in HT-29 human colon cancer cells.
As previously demonstrated, the synthetic bile acid derivatives mediate anti-proliferative properties in a variety of human… 
2001
2001
Apoptotic activity of novel bile acid derivatives in human leukemic T cells through the activation of caspases.
The therapeutic efficacies of bile acids, such as ursodeoxycholic acid (UDCA) and chenodeoxycholic acid (CDCA), have been widely… 
1999
1999
Inhibition of initiation of simian virus 40 DNA replication in vitro by the ursodeoxycholic acid and its derivatives.
1997
1997
Anti-angiogenic activity of ursodeoxycholic acid and its derivatives.
1997
1997
Induction of apoptosis in HepG2 human hepatocellular carcinoma cells by a novel derivative of ursodeoxycholic acid (UDCA)
The effects of ursodeoxycholic acid (UDCA) and its novel derivative, named as HS-1030, on the proliferation of HepG2, human… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)